Question 1

What is the Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer?

Accepted Answer

Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer is , while it's Molecular Formula is . Used in Medical Treatments:
Immunoglobulin G1, anti-(human LPAM-1) is used as a targeted therapy for conditions related to the LPAM-1 molecule. By binding to the LPAM-1 molecule, this immunoglobulin can modulate the biological processes associated with it, potentially leading to therapeutic effects in various diseases.
Used in Research:
Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer is also used as a research tool to study the role of the LPAM-1 molecule in various biological processes. By using this immunoglobulin to target and manipulate the LPAM-1 molecule, researchers can gain insights into its function and potential involvement in disease mechanisms.
Used in Drug Development:
Immunoglobulin G1, anti-(human LPAM-1) can be employed in the development of new drugs targeting the LPAM-1 molecule. By understanding the interactions between this immunoglobulin and the LPAM-1 molecule, researchers can design drugs that specifically target this molecule, potentially leading to more effective treatments for related diseases.
Used in Diagnostic Applications:
This immunoglobulin can be utilized in diagnostic assays to detect the presence or levels of the LPAM-1 molecule in biological samples. By using this immunoglobulin as a specific probe, diagnostic tests can be developed to aid in the diagnosis and monitoring of diseases associated with the LPAM-1 molecule.
Used in Immunotherapy:
Immunoglobulin G1, anti-(human LPAM-1) can be employed in immunotherapy approaches to modulate the immune response in diseases related to the LPAM-1 molecule. By targeting this molecule, this immunoglobulin can potentially enhance or suppress immune responses, leading to therapeutic effects in various conditions.
Used in Biomarker Development:
Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer can be used in the identification and validation of the LPAM-1 molecule as a potential biomarker for diseases or conditions. By studying the interactions between this immunoglobulin and the LPAM-1 molecule, researchers can determine its potential as a diagnostic or prognostic indicator.
Used in Application Industry:
Immunoglobulin G1, anti-(human LPAM-1) is used as a targeted therapeutic agent in the pharmaceutical industry for the development of treatments related to the LPAM-1 molecule and its associated biological processes. Its specific targeting ability makes it a valuable tool in the discovery and development of new drugs for various diseases.

Question 2

What is the CAS number for Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer?

Accepted Answer

The CAS number of Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer is 943609-66-3.

Question 3

What is Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer (943609-66-3) used for?

Accepted Answer

Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyer's patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer is a chemical compound composed of monoclonal antibodies that specifically target the human LPAM-1 molecule. This molecule, also known as lymphocyte Peyer's patch high endothelial venule adhesion molecule 1, plays a crucial role in various biological processes. Immunoglobulin G1, anti-(human LPAM-1 (lymphocyte Peyers patch high endothelial venule adhesion molecule 1)) (human-mouse monoclonal LDP-02 gamma1-chain), disulfide with human-mouse monoclonal LDP-02 light chain, dimer is formed by the connection of a gamma1-chain and a light chain through disulfide bonds, creating a dimeric structure. Due to its targeted nature, this immunoglobulin has potential applications in medical treatments and research related to the LPAM-1 molecule and its associated biological functions.

Home

About us

Products

small-molecule inhibitor

intermediate

Pharmaceutical intermediate

Biochemical reagent

fire retardant

chemical reagent

ionic liquid

Inhibitor

Antibody

Pesticide

New materials

Customization

Nucleosides

Food additives

Supplement

API

Pharmaceutical intermediates

Biological products

Polypeptides

Chemical reagents

Small molecule inhibitors

Organic electronic chemical materials

Technical Support

News

Contact Us

Inquiry

Product classification

Contact us

943609-66-3

Product Details

Manufacturers supply cost-effective and customizable Vedolizumab 943609-66-3

Relevant Products